Filing Details
Pacira BioSciences, Inc. (NASDAQ:PCRX) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event.
8k filedNASDAQ:PCRX
Pacira BioSciences, Inc. (PCRX) Reports Material Event to SEC
Filing Details Pacira BioSciences, Inc. (NASDAQ:PCRX) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event. Market Context…
Market Context
Pacira BioSciences, Inc.'s stock currently trades at $25.37 with a market capitalization of $1.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Pacira BioSciences, Inc.'s stock.
All SEC filings for Pacira BioSciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PCRX Stock Page
Frequently Asked Questions
Where can I read PCRX's SEC filings?
Browse all filings on our PCRX SEC filings page.
What types of SEC filings does Pacira BioSciences, Inc. file?
Public companies like Pacira BioSciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.